On August 31, 2022 Orexo AB (Publ.), (STO:ORX) (OTCQX:ORXOY), which develops improved pharmaceuticals and evidence-based digital therapeutics primarily targeting the US market where its commercial organization is located, reported the company will participate in Pareto Securities’ 13th Annual Healthcare Conference, that takes place on September 7-8, 2022, at Sergel Hub, Sveavägen 10 A, Stockholm, Sweden (Press release, Orexo, AUG 31, 2022, View Source [SID1234618844]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On September 7th at 2.30 pm CET, Nikolaj Sørensen, President and CEO at Orexo, will give a company presentation. Nikolaj Sørensen and the company’s new CFO Fredrik Järrsten will also be available for 1-1 meetings during the conference.